SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-047412
Filing Date
2021-09-09
Accepted
2021-09-09 08:20:51
Documents
16
Period of Report
2021-09-09
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acor-8k_20210909.htm   iXBRL 8-K 39320
2 CLEM EMPLOYMENT AGREEMENT acor-ex101_6.htm EX-10.1 68933
3 PRESS RELEASE acor-ex991_43.htm EX-99.1 17763
4 GRAPHIC gs5fjtyxu524000001.jpg GRAPHIC 4764
5 GRAPHIC gsaa4fsblvtj000001.jpg GRAPHIC 39776
  Complete submission text file 0001564590-21-047412.txt   331832

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA acor-20210909.xsd EX-101.SCH 5677
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE acor-20210909_lab.xml EX-101.LAB 18595
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acor-20210909_pre.xml EX-101.PRE 11029
9 EXTRACTED XBRL INSTANCE DOCUMENT acor-8k_20210909_htm.xml XML 3413
Mailing Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502
Business Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502 914-347-4300
ACORDA THERAPEUTICS INC (Filer) CIK: 0001008848 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31938 | Film No.: 211243588
SIC: 2836 Biological Products, (No Diagnostic Substances)